Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2017

Nov 30, 2017

29871_dirs_2017-11-30_9b34f3f4-4777-4335-b60a-fb6cf8105c13.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2017-11-28

Reporting Person: Holzrichter Julie (Sr MD Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-28 Common Stock Class A M 4580 $54.37 Acquired 45563 Direct
2017-11-28 Common Stock Class A S 4580 $144.0839 Disposed 40983 Direct
2017-11-28 Common Stock Class A M 8340 $54.3 Acquired 49323 Direct
2017-11-28 Common Stock Class A S 8340 $144.0839 Disposed 40983 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-28 Non-Qualified Stock Option (right to buy) $54.3 M 8340 Disposed 2020-09-15 Common Stock Class A (8340) Direct
2017-11-28 Non-Qualified Stock Option (right to buy) $54.37 M 4580 Disposed 2021-09-15 Common Stock Class A (4580) Direct

Footnotes

F1: On November 28, 2017, Ms. Holzrichter sold an aggregate of 12,920 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $144.00 to $144.23. The Company maintains a record of the transactions and copies will be provided upon request.

F2: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option.

F3: As of 9/15/2015, this option vested with respect to 100% of the granted number of shares covered by the option.